171 related articles for article (PubMed ID: 18416825)
1. Structural insights on the pamoic acid and the 8 kDa domain of DNA polymerase beta complex: towards the design of higher-affinity inhibitors.
Hazan C; Boudsocq F; Gervais V; Saurel O; Ciais M; Cazaux C; Czaplicki J; Milon A
BMC Struct Biol; 2008 Apr; 8():22. PubMed ID: 18416825
[TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.
Hu HY; Horton JK; Gryk MR; Prasad R; Naron JM; Sun DA; Hecht SM; Wilson SH; Mullen GP
J Biol Chem; 2004 Sep; 279(38):39736-44. PubMed ID: 15258144
[TBL] [Abstract][Full Text] [Related]
3. Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta.
Barakat K; Tuszynski J
J Mol Graph Model; 2011 Feb; 29(5):702-16. PubMed ID: 21194999
[TBL] [Abstract][Full Text] [Related]
4. Sulfoquinovosylmonoacylglycerol inhibitory mode analysis of rat DNA polymerase beta.
Kasai N; Mizushina Y; Murata H; Yamazaki T; Ohkubo T; Sakaguchi K; Sugawara F
FEBS J; 2005 Sep; 272(17):4349-61. PubMed ID: 16128805
[TBL] [Abstract][Full Text] [Related]
5. Structure of lithocholic acid binding to the N-terminal 8-kDa domain of DNA polymerase beta.
Mizushina Y; Ohkubo T; Sugawara F; Sakaguchi K
Biochemistry; 2000 Oct; 39(41):12606-13. PubMed ID: 11027140
[TBL] [Abstract][Full Text] [Related]
6. Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta.
Mizushina Y; Kasai N; Miura K; Hanashima S; Takemura M; Yoshida H; Sugawara F; Sakaguchi K
Biochemistry; 2004 Aug; 43(33):10669-77. PubMed ID: 15311928
[TBL] [Abstract][Full Text] [Related]
7. Recognition of template-primer and gapped DNA substrates by the human DNA polymerase beta.
Rajendran S; Jezewska MJ; Bujalowski W
J Mol Biol; 2001 May; 308(3):477-500. PubMed ID: 11327782
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutational analysis of structural interactions of low molecule compounds binding to the N-terminal 8 kDa domain of DNA polymerase beta.
Murakami S; Kamisuki S; Takata K; Kasai N; Kimura S; Mizushina Y; Ohta K; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2006 Nov; 350(1):7-16. PubMed ID: 16996474
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanisms of rat polymerase beta-ssDNA interactions. Quantitative fluorescence stopped-flow analysis of the formation of the (Pol beta)(16) and (Pol beta)(5) ssDNA binding mode.
Jezewska MJ; Rajendran S; Galletto R; Bujalowski W
J Mol Biol; 2001 Nov; 313(5):977-1002. PubMed ID: 11700054
[TBL] [Abstract][Full Text] [Related]
10. Transition between different binding modes in rat DNA polymerase beta-ssDNA complexes.
Jezewska MJ; Rajendran S; Bujalowski W
J Mol Biol; 1998 Dec; 284(4):1113-31. PubMed ID: 9837730
[TBL] [Abstract][Full Text] [Related]
11. Interactions of the 8-kDa domain of rat DNA polymerase beta with DNA.
Jezewska MJ; Rajendran S; Bujalowski W
Biochemistry; 2001 Mar; 40(11):3295-307. PubMed ID: 11258949
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structural model analysis of the binding site of lithocholic acid, an inhibitor of DNA polymerase beta and DNA topoisomerase II.
Mizushina Y; Kasai N; Sugawara F; Iida A; Yoshida H; Sakaguchi K
J Biochem; 2001 Nov; 130(5):657-64. PubMed ID: 11686928
[TBL] [Abstract][Full Text] [Related]
13. NMR determination of lysine pKa values in the Pol lambda lyase domain: mechanistic implications.
Gao G; DeRose EF; Kirby TW; London RE
Biochemistry; 2006 Feb; 45(6):1785-94. PubMed ID: 16460025
[TBL] [Abstract][Full Text] [Related]
14. The primary DNA-binding subsite of the rat pol β. Energetics of interactions of the 8-kDa domain of the enzyme with the ssDNA.
Jezewska MJ; Szymanski MR; Bujalowski W
Biophys Chem; 2011 Jul; 156(2-3):115-27. PubMed ID: 21382659
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta.
Boudsocq F; Benaim P; Canitrot Y; Knibiehler M; Ausseil F; Capp JP; Bieth A; Long C; David B; Shevelev I; Frierich-Heinecken E; Hübscher U; Amalric F; Massiot G; Hoffmann JS; Cazaux C
Mol Pharmacol; 2005 May; 67(5):1485-92. PubMed ID: 15703384
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of the lyase domain of human DNA polymerase lambda.
DeRose EF; Kirby TW; Mueller GA; Bebenek K; Garcia-Diaz M; Blanco L; Kunkel TA; London RE
Biochemistry; 2003 Aug; 42(32):9564-74. PubMed ID: 12911298
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional solution structure of the N-terminal domain of DNA polymerase beta and mapping of the ssDNA interaction interface.
Liu D; Prasad R; Wilson SH; DeRose EF; Mullen GP
Biochemistry; 1996 May; 35(20):6188-200. PubMed ID: 8639559
[TBL] [Abstract][Full Text] [Related]
18. Rat polymerase beta binds double-stranded DNA using exclusively the 8-kDa domain. Stoichiometries, intrinsic affinities, and cooperativities.
Jezewska MJ; Galletto R; Bujalowski W
Biochemistry; 2003 May; 42(19):5955-70. PubMed ID: 12741854
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structural model analysis of the binding site of an inhibitor, nervonic acid, of both DNA polymerase beta and HIV-1 reverse transcriptase.
Kasai N; Mizushina Y; Sugawara F; Sakaguchi K
J Biochem; 2002 Nov; 132(5):819-28. PubMed ID: 12417034
[TBL] [Abstract][Full Text] [Related]
20. DNA polymerase beta (pol β) inhibitors: a comprehensive overview.
Barakat KH; Gajewski MM; Tuszynski JA
Drug Discov Today; 2012 Aug; 17(15-16):913-20. PubMed ID: 22561893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
